Search

Your search keyword '"Witte, T"' showing total 1,761 results

Search Constraints

Start Over You searched for: Author "Witte, T" Remove constraint Author: "Witte, T" Publication Type Academic Journals Remove constraint Publication Type: Academic Journals
1,761 results on '"Witte, T"'

Search Results

6. S2k-Leitlinie (Kurzfassung): Management der Großgefäßvaskulitiden

7. S2k-Leitlinie: Management der Großgefäßvaskulitiden

13. Breast Cancer in Systemic Lupus Erythematosus

15. Früh- und Screeningsprechstunden: Ein notwendiger Weg zur besseren Frühversorgung in der internistischen Rheumatologie?: Rheumatologische Früh- und Screeningsprechstundenmodelle in Deutschland

17. In Search of the Excellent Literature Teacher: An Inductive Approach to Constructing Professional Teaching Standards

20. Long-term follow-up of a retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic transplantation from matched related donors in myelodysplastic syndromes

23. Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT

28. Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party

31. Brauchen wir noch klinische Studien in der Rheumatologie?

35. Erythropoiesis‐stimulating agents significantly delay the onset of a regular transfusion need in nontransfused patients with lower‐risk myelodysplastic syndrome

41. Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS): phase I results of an ongoing phase I/II study of the leukemia groups of EORTC and GIMEMA (EORTC GIMEMA 06061/AML-14A trial)

45. O08 - Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: LYMPHOPENIA IS HIGHLY PREVALENT IN MDS AND PROVIDES ADDITIONAL PROGNOSTIC INFORMATION FOR IPSS-R VERY-LOW AND LOW-RISK PATIENTS. AN ANALYSIS FROM THE EU-MDS REGISTRY

46. Reduced intensity-conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation: a study by the European Group for Blood and Marrow Transplantation

Catalog

Books, media, physical & digital resources